AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today issued a presentation highlighting why shareholders should NOT elect the four director candidates nominated by a group of ...
The modern and conveniently situated property was purchased for $48.0 million, which represents $935 per leasable residential square foot. CAPREIT assumed $29.7 million in mortgage debt, which carries ...